Invention Grant
- Patent Title: Pyrrolidinium derivatives as M3 muscarnic receptor antagonists
- Patent Title (中): 吡咯烷鎓衍生物作为M3毒蕈碱受体拮抗剂
-
Application No.: US11721058Application Date: 2005-12-22
-
Publication No.: US08383625B2Publication Date: 2013-02-26
- Inventor: Neil J Press , Collingwood P Stephen
- Applicant: Neil J Press , Collingwood P Stephen
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Daniel Woods
- Priority: GB0428416.2 20041224
- International Application: PCT/EP2005/013896 WO 20051222
- International Announcement: WO2006/066928 WO 20060629
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/497
Abstract:
Compounds of formula (I) in salt or zwitterionic form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Public/Granted literature
- US20090291960A1 PYRROLINIDIUM DERIVATIVES AS M3 MUSCARINIC RECEPTORS Public/Granted day:2009-11-26
Information query
